Thiazolidine: A Potent Candidate for Central Nervous System Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-6166|17|1|26-29

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.17, Iss.1, 2017-02, pp. : 26-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabotropic Glutamate Receptors in Central Nervous System Diseases

By  

Current Drug Targets, Vol. 17, Iss. 5, 2016-04 ,pp. : 538-616

Bentham Science Publishers

Access to resources Recommend Favorite

ADP-Ribosyl Cyclase as a Therapeutic Target for Central Nervous System Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-09 ,pp. : 193-210

Bentham Science Publishers

Access to resources Recommend Favorite

Central Nervous System Involvement in Pediatric Rheumatic Diseases: Current Concepts in Treatment

By  

Current Pharmaceutical Design, Vol. 14, Iss. 13, 2008-05 ,pp. : 1295-1301

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nogo Receptor Complex in Diseases of the Central Nervous System

By  

Current Medicinal Chemistry, Vol. 18, Iss. 2, 2011-01 ,pp. : 234-244

Bentham Science Publishers

Access to resources Recommend Favorite

Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System

By  

Current Pharmaceutical Design, Vol. 17, Iss. 5, 2011-01 ,pp. : 410-423

Bentham Science Publishers

Access to resources Recommend Favorite